Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | EED | O75530 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HTR6 | P50406 | 2/20 | 0.30 |
| ▸ | PIM1 | P11309 | 1/20 | 0.30 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | UBE2N | P61088 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20193224 | 0.82 | CHUK (0.30) | — | |
| SCHEMBL20193225 | 0.81 | PDE4A (0.37) | L3MBTL1BRD4EEDMEN1KMT2A | |
| SCHEMBL20193178 | 0.81 | L3MBTL1 (0.39) | L3MBTL1BRD4EEDMEN1KMT2A | |
| SCHEMBL20193169 | 0.73 | — | — | |
| SCHEMBL16608400 | 0.71 | PDE4A (0.37) | L3MBTL1BRD4EEDHTR6PIM1 | |
| SCHEMBL20307364 | 0.71 | HTR6 (0.34) | L3MBTL1MEN1KMT2AHTR6KDM4E | |
| SCHEMBL19114534 | 0.71 | HTR6 (0.47) | L3MBTL1HTR6KDM4EUBE2N | |
| SCHEMBL16608643 | 0.71 | L3MBTL1 (0.39) | L3MBTL1BRD4EEDHTR6PIM1 | |
| SCHEMBL19629512 | 0.69 | L3MBTL1 (0.41) | L3MBTL1BRD4MEN1KMT2AHTR6 | |
| SCHEMBL16608384 | 0.69 | L3MBTL1 (0.44) | L3MBTL1BRD4HTR6KDM4EUBE2N |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9981963-B2 | 3-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-c]pyridine derivatives as NIK inhibitors | JANSSEN PHARMACEUTICA NV (BE) | 2018-05-29 | — | — | US | disclosed |